TherapeuticsMD (TXMD) Work In Process (2018 - 2022)
TherapeuticsMD's (TXMD) quarterly Work In Process came in at $218000.0 in Q3 2022, down 68.31% on a YoY basis from $688000.0 in Q3 2021, and down 87.05% quarter-over-quarter from $1.7 million in Q2 2022.
Analysis
TherapeuticsMD (TXMD) Work In Process (2018 - 2022) Analysis & Trends
TherapeuticsMD (TXMD) has reported Work In Process for 5 consecutive years, with $218000.0 the latest figure, recorded in Q3 2022.
- For the quarter ending Q3 2022, Work In Process fell 68.31% year-over-year to $218000.0; the trailing twelve-month figure through Sep 2022 stood at $218000.0 (down 68.31% YoY), and the FY2021 full-year result was $1.6 million, up 83.46% from the prior year.
- Work In Process slipped to $218000.0 in Q3 2022 per TXMD's latest filing, from $1.7 million in the prior quarter.
- Across five years, Work In Process topped out at $1.7 million in Q2 2022 and bottomed at $83911.0 in Q3 2018.
- Historically, Work In Process has averaged $849310.4 across 5 years, with a median of $808694.0 in 2019.
- The sharpest annual moves came in 2019 and 2022: Work In Process surged 1098.38% in 2019, then tumbled 68.31% in 2022.
- Over 5 years, Work In Process stood at $339312.0 in 2018, then soared by 248.37% to $1.2 million in 2019, then dropped by 24.28% to $895000.0 in 2020, then soared by 83.46% to $1.6 million in 2021, then tumbled by 86.72% to $218000.0 in 2022.
- According to Business Quant data, Work In Process over the past three periods registered $218000.0, $1.7 million, and $1.2 million for Q3 2022, Q2 2022, and Q1 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 218,000.00 |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 688,000.00 |
| Jun 30, 2021 | 744,000.00 |
| Dec 31, 2020 | 895,000.00 |
| Sep 30, 2020 | 440,149.00 |
| Jun 30, 2020 | 1.55 Mn |
| Dec 31, 2019 | 1.18 Mn |
| Sep 30, 2019 | 1.01 Mn |
| Mar 31, 2019 | 808,694.00 |
| Dec 31, 2018 | 339,312.00 |
| Sep 30, 2018 | 83,911.00 |
| Jun 30, 2018 | 227,877.00 |